Cometriq (cabozantinib capsule) - Exelixis
Yervoy (ipilimumab) - BMS
ABP 206 (nivolumab biosimilar) - Amgen
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
BCD-263 (nivolumab biosimilar) - Biocad
Cabometyx (cabozantinib tablet) - Exelixis
http://clinicaltrials.gov/ct2/show/NCT03866382
 
Feb 12, 2026
 
Next